Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria – PubMed
In patients with CKD and albuminuria, randomization to dapagliflozin was associated with modest reductions in systolic and diastolic BP.
In patients with CKD and albuminuria, randomization to dapagliflozin was associated with modest reductions in systolic and diastolic BP.
A-A is a coalition of charities, patient groups, patients, carers, medical groups and allied professionals. A-A provides support, information, education, and awareness to all those…
Two catheter-directed thrombectomy devices demonstrated efficacy and safety in the treatment of acute intermediate-risk pulmonary embolism, speakers reported.The results of the investigational device exemption APEX-AV…
Aims Some patients with cardiac dystrophinopathy die suddenly. Whether such deaths are preventable by specific antiarrhythmic management or simply indicate heart failure overwhelming medical therapies…
National Institutes of Health and the US Department of Veterans Affairs.
The CardioNerds Academy harnesses the entire CardioNerds platform to facilitate mentorship, networking, & collaboration.
Important Notice: All ACC-related web platforms will be unavailable from Friday, May 10 until Tuesday, May 21 as part of system-wide upgrades to ACC’s digital…
A total of 21 late-breaking science presentations are scheduled for Heart Rhythm 2024 in Boston.
2024 Perfusion Conference | #PerfCon2024 The Denton A. Cooley Auditorium | The Texas Heart Institute | Houston, Texas The Texas Heart Institute 2024 Perfusion Conference…
BACKGROUND: Quantification of left atrial (LA) conduit function and its contribution to left ventricular (LV) filling is challenging because it requires simultaneous measurements of both…